Abstract:Psychostimulant addiction, most notably cocaine and amphetamine - type stimulants are an important public health problem worldwide. It appears that social factors may influence the initiation, maintenance and recovery from addictions. Several animal models have been developed to study addiction, highlighting drug self-administration (SA) and the conditioned place preference (CPP) paradigms. These models have been modified to accurately reflect the characteristics of drug addiction in its different stages. One factor that clearly plays a major role in addiction is stress, which is a risk factor not only for the initiation, maintenance and escalation of drug consumption, but also for relapse. In animal models, stress for itself can provoke reinstatement of self-administration or CPP. The relationship between stress and addiction is very tight. One example is the close anatomical relationship of some areas that share these two phenomena. It seems obvious to think that the main source of stress in humans is social interaction. The aim of the present review is to gather the current information regarding the role of social stress in the addiction to psychostimulant drugs in animal models. First, we briefly describe the mechanisms by which stress exerts its effects and the basic concepts of addiction. We will try to establish common pathways of stress and addiction, to address later social stress effects on different stages of addiction. Then, we will address pharmacological therapies and preventive factors that counteract the enhancing effects of social stress in addiction. Finally, we will analyze how negative environmental conditions may induce individuals to increased vulnerability to drugs, and how favorable environmental conditions may have protective and curative effects against addiction. In this sense, we also analyze the importance of social interactions and their ability to modulate the different stages of addiction. As a conclusion, and despite the scarcity of the research, social stress exposure increases the initiation of psychostimulant consumption and the vulnerability to relapse in animal models of addiction. Studies on the mechanisms underlying the effects of social stress and how it can be counteracted pharmacologically, are research areas that should be explored in the future. At the same time, translational research on the effects of environmental conditions and positive social interactions, which have been shown to have a critical role in addictions, should be encouraged.

New Derivatives from Microbial Transformation of Ent‐kaur‐16‐en‐19‐oic Acid by Cunninghamella Echinulata

Two New P-Methoxyphenyl-type Derivatives from a Saline-Lake Derived Streptomyces Sp. XZB32.

Microbe-mediate transformation of echinocystic acid by whole cells of filamentous fungus Cunninghamella blakesleana CGMCC 3.910

A Novel One-Step Microbial Transformation of Betulin to Betulinic Acid Catalysed by Cunninghamella Blakesleeana

Microbial transformation of acetyl-11-keto-boswellic acid by Cunninghamella elegans

Two new echinocystic acid derivatives catalyzed by filamentous fungus Gliocladium roseum CGMCC 3.3657

Biotransformation of betulinic acid by Circinella muscae and Cunninghamella echinulata to discover anti-inflammatory derivatives

Microbial Transformation of Yakuchinone A and Cytotoxicity Evaluation of Its Metabolites

Microbial Glycosylation of Tanshinone Iia by Cunninghamella Elegans As 3.2028

Alokicenones A-H, Eight Tetrahydroanthracenes from the Mangrove-Derived Streptomyces Sp. HN-A101

Bioactive Staurosporine Derivatives from the Streptomyces Sp. NB-A13.

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Regioselective Hydroxylation of Lathyrane Diterpenoids Biocatalyzed by Microorganisms and Its Application in Integrated Synthesis

Impact of social stress in addiction to psychostimulants: what we know from animal models.

Selective Oxidation-Reduction and Esterification of Asiatic Acid by Pestalotiopsis Microspora and Anti-Hcv Activity

Microbial transformation of 2-amino-4-methyl-3-nitropyridine

Microbial biotransformation of cryptotanshinone by Cunninghamella elegans and its application for metabolite identification in rat bile.

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.

Biotransformation of Patchoulol by Cunninghamella Echinulata Var. Elegans.

New ent-Kaurane and cleistanthane diterpenoids with potential cytotoxicity from Phyllanthus acidus (L.) Skeels

Biotransformation of Triptolide by Cunninghamella Blakesleana